The global in vitro diagnostics market is anticipated to increase by USD 38 billion till 2028 at an average annual growth of 6.1 percent as per the latest report by Gen Consulting Company.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market data on in vitro diagnostics can be segmented by product: instruments, reagents, software & services. In vitro diagnostics market is further segmented by technology: clinical chemistry & immunochemistry, clinical microbiology, hematology, molecular diagnostics (MDx), POC testing, self-monitoring of blood glucose (SMBG), tissue diagnostics, others. Globally, the clinical chemistry & immunochemistry segment made up the largest share of the in vitro diagnostics market. Based on application, the in vitro diagnostics market is segmented into: autoimmune diseases, cardiac diseases, diabetes, infectious diseases, nephrological diseases, oncology, others. On the basis of end user, the in vitro diagnostics market also can be divided into: hospitals, laboratories, homecare, others. In vitro diagnostics market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).
The global in vitro diagnostics market is highly competitive. As of 2021, the major players in the global in vitro diagnostics market were Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Illumina Inc., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Qiagen N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Werfen S.A.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
- Get a detailed picture of the Global In Vitro Diagnostics Market
- Identify segments/areas to invest in over the forecast period in the Global In Vitro Diagnostics Market
- Understand the competitive environment, the market's leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Part 1. Summary
Part 2. Introduction
· Study period
· Geographical scope
· Market segmentation
Part 3. In vitro diagnostics market overview
Part 4. Market breakdown by product
· Instruments
· Reagents
· Software & services
Part 5. Market breakdown by technology
· Clinical chemistry & immunochemistry
· Clinical microbiology
· Hematology
· Molecular diagnostics (MDx)
· POC testing
· Self-monitoring of blood glucose (SMBG)
· Tissue diagnostics
· Others
Part 6. Market breakdown by application
· Autoimmune diseases
· Cardiac diseases
· Diabetes
· Infectious diseases
· Nephrological diseases
· Oncology
· Others
Part 7. Market breakdown by end user
· Hospitals
· Laboratories
· Homecare
· Others
Part 8. Market breakdown by region
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
Part 9. Key companies
· Abbott Laboratories
· Becton, Dickinson and Company
· bioMerieux SA
· Bio-Rad Laboratories, Inc.
· Danaher Corporation
· F. Hoffmann-La Roche AG
· Hologic, Inc.
· Illumina, Inc.
· Ortho-Clinical Diagnostics, Inc.
· PerkinElmer, Inc.
· Qiagen N.V.
· Siemens Healthineers AG
· Sysmex Corporation
· Thermo Fisher Scientific, Inc.
· Werfen, S.A.
Part 10. Methodology
Executive Summary
Azoth Analytics has released a research report titled "Global Infectious Disease In vitro Diagnostics Market (2024 Edition)" which provides a complete analysis of the Global Infectious Disease In vitro Diagnostics industry in terms of market segmentation By Technology ...
The In Vitro Diagnostics (IVD) Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The In - Vitro ADME Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactur...
The In Vitro Diagnostics High-Specification Products Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competiti...
The Virtual Diagnostics And Consultations Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
This report gives an insight into the global Food Diagnostics Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall market size...
This report gives an insight into the global Respiratory Diagnostics Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall mark...
This report gives an insight into the global Tissue Diagnostics Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall market si...
Overview of the Global On-Board Diagnostics System Cyber Security Market:
The report discusses everything a marketer requires before investing in the global On-Board Diagnostics System Cyber Security Market during t...
Overview of the Global ESR1 Mutated Metastatic Breast Cancer Diagnostics Market:
The report discusses everything a marketer requires before investing in the global ESR1 Mutated Metastatic Breast Cancer Diagnostics M...